+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Systems Market by Route of Administration, Technology, Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Drug Delivery Systems Market by Route of Administration, Technology, Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Drug Delivery Systems Market by Route of Administration, Technology, Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013573
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global drug delivery systems market is at a turning point, driven by technological advances and increasing demand for patient-friendly solutions. Senior decision-makers seek clear, actionable insights to navigate investment, competitive positioning, and supply chain resilience in this evolving landscape.

Market Snapshot: Drug Delivery Systems Market

The Drug Delivery Systems Market grew from USD 39.02 billion in 2024 to USD 41.29 billion in 2025. It is expected to continue growing at a CAGR of 5.76%, reaching USD 54.64 billion by 2030.

Scope & Segmentation

This report delivers a comprehensive breakdown of the drug delivery systems market across technology, product, end user, and geography.

  • Routes of Administration: Includes dermal (creams, gels, transdermal patches), oral (capsules, tablets, liquids), parenteral (intramuscular, intravenous, subcutaneous), and respiratory (dry powder inhalers, metered dose inhalers, nebulizers).
  • Technologies: Covers depots (biodegradable and non-biodegradable), liposomes (conventional and stealth), microneedles (coated, hollow, solid), and nanoparticles (inorganic, lipid-based, polymeric).
  • Product Types: Examines auto-injectors, inhalers, insulin pumps, patches, and syringes used across varied indications.
  • Applications: Spans key therapeutic domains such as cardiovascular, diabetes, neurology, oncology, and pain management.
  • End Users: Explores scenarios involving ambulatory care centers, clinics, home care settings, and hospitals.
  • Distribution Channels: Encompasses direct sales, hospital and retail pharmacies, as well as online channels.
  • Regions Covered: Comprehensive analysis of the Americas (including major US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (across over fifteen countries), and Asia-Pacific (featuring developed and emerging markets in China, India, Japan, Australia, South Korea, and Southeast Asia).
  • Company Coverage: Profiles leading multinationals and disruptors, such as Johnson & Johnson, Roche Holding AG, Novartis AG, Pfizer Inc., Sanofi S.A., Baxter International Inc., Becton, Dickinson and Company, Abbott Laboratories, West Pharmaceutical Services, Inc., and Catalent, Inc.

Key Takeaways

  • Market evolution is strongly influenced by rapid innovations in material science, digital health, and patient-centric device design, supporting new therapeutic modalities.
  • Integration of smart sensors and connected platforms allows real-time monitoring and adaptive dosing, driving demand for smarter, more responsive delivery technologies.
  • Strategic partnerships between pharmaceutical, biotech, and medtech players accelerate the commercialization of combination products and novel digital therapeutics.
  • Shifting regulatory expectations and expedited approvals reward companies with robust compliance expertise and agile development strategies.
  • Emerging regions exhibit growing demand for scalable, affordable devices, creating competitive opportunities for both incumbents and innovators targeting diverse end users.
  • Sustainability and eco-design considerations are becoming central to investment decisions and long-term competitiveness for manufacturers and their stakeholders.

Tariff Impact

The introduction of new US tariffs in 2025 has created significant disruption across the drug delivery supply chain. Manufacturers relying on imported polymers, biologics, or highly engineered components are experiencing higher input costs, driving a shift toward localized production and supplier diversification. Strategic collaborations with domestic contract development and manufacturing partners have become essential in safeguarding product quality and regulatory compliance, as companies adapt operations to manage cost pressures and maintain supply chain resilience.

Methodology & Data Sources

This analysis is based on extensive secondary research—including regulatory filings and peer-reviewed industry sources—supplemented by targeted primary interviews with executives and R&D leaders. Quantitative and qualitative data were triangulated across multiple channels to ensure reliability and strategic relevance.

Why This Report Matters

  • Empowers senior leaders with clear, actionable insights to inform critical investment, product development, and sourcing strategies across global markets.
  • Delivers a structured view of the evolving drug delivery systems landscape, highlighting new technologies and emerging partnership models to support informed decision-making.
  • Enables companies to identify strategic opportunities and mitigate risks—from regulatory change to shifting supply chain dynamics—benefiting long-term planning and commercial performance.

Conclusion

The drug delivery systems market offers diverse growth pathways for stakeholders prepared to adapt to technological and regulatory change. Leveraging this report will inform strategy, drive innovation, and guide operational resilience in a complex, opportunity-rich sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Delivery Systems Market, by Route of Administration
8.1. Introduction
8.2. Dermal
8.2.1. Creams and Gels
8.2.2. Transdermal Patches
8.3. Oral
8.3.1. Capsules
8.3.2. Liquid Formulations
8.3.3. Tablets
8.4. Parenteral
8.4.1. Intramuscular
8.4.2. Intravenous
8.4.3. Subcutaneous
8.5. Respiratory
8.5.1. Dry Powder Inhalers
8.5.2. Metered Dose Inhalers
8.5.3. Nebulizers
9. Drug Delivery Systems Market, by Technology
9.1. Introduction
9.2. Depots
9.2.1. Biodegradable Depots
9.2.2. Non-Biodegradable Depots
9.3. Liposomes
9.3.1. Conventional Liposomes
9.3.2. Stealth Liposomes
9.4. Microneedles
9.4.1. Coated Microneedles
9.4.2. Hollow Microneedles
9.4.3. Solid Microneedles
9.5. Nanoparticles
9.5.1. Inorganic Nanoparticles
9.5.2. Lipid Based Nanoparticles
9.5.3. Polymeric Nanoparticles
10. Drug Delivery Systems Market, by Product Type
10.1. Introduction
10.2. Auto-Injectors
10.3. Inhalers
10.4. Insulin Pumps
10.5. Patches
10.6. Syringes
11. Drug Delivery Systems Market, by Application
11.1. Introduction
11.2. Cardiovascular
11.3. Diabetes
11.4. Neurology
11.5. Oncology
11.6. Pain Management
12. Drug Delivery Systems Market, by End User
12.1. Introduction
12.2. Ambulatory Care Centers
12.3. Clinics
12.4. Home Care Settings
12.5. Hospitals
13. Drug Delivery Systems Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Hospital Pharmacies
13.4. Online Pharmacies
13.5. Retail Pharmacies
14. Americas Drug Delivery Systems Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Drug Delivery Systems Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Drug Delivery Systems Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. Roche Holding AG
17.3.3. Novartis AG
17.3.4. Pfizer Inc.
17.3.5. Sanofi S.A.
17.3.6. Baxter International Inc.
17.3.7. Becton, Dickinson and Company
17.3.8. Abbott Laboratories
17.3.9. West Pharmaceutical Services, Inc.
17.3.10. Catalent, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRUG DELIVERY SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. DRUG DELIVERY SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CREAMS AND GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY BIODEGRADABLE DEPOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NON-BIODEGRADABLE DEPOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONVENTIONAL LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STEALTH LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COATED MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOLLOW MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLID MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INORGANIC NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPID BASED NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY POLYMERIC NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 97. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 99. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 100. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 101. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 102. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 104. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 105. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 106. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 107. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 115. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 119. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 120. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 184. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 185. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 187. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 190. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 191. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 192. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 197. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 198. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 199. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 200. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 201. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 205. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 226. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 227. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 228. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 229. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 231. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 232. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 233. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 234. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 240. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 241. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 242. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 243. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 245. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 246. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 247. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 248. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 295. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 296. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 297. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 298. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 299. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 301. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 302. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 303. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 304. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 313. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 315. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 323. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DERMAL, 2018-2030 (USD MILLION)
TABLE 324. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 325. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 326. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY, 2018-2030 (USD MILLION)
TABLE 327. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 328. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOTS, 2018-2030 (USD MILLION)
TABLE 329. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIPOSOMES, 2018-2030 (USD MILLION)
TABLE 330. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICRONEEDLES, 2018-2030 (USD MILLION)
TABLE 331. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
TABLE 332. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 333. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 336. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug Delivery Systems market report include:
  • Johnson & Johnson
  • Roche Holding AG
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • West Pharmaceutical Services, Inc.
  • Catalent, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 41.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 54.64 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Novel Drug Delivery Systems Market by Route of Administration, Technology, Application, Product Type, End User - Global Forecast to 2030 - Product Image

Novel Drug Delivery Systems Market by Route of Administration, Technology, Application, Product Type, End User - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Targeted Drug Delivery System Market by Therapeutic Application, Delivery Route, Technology, Drug Type, End User, Sales Channel - Global Forecast to 2030 - Product Image

Targeted Drug Delivery System Market by Therapeutic Application, Delivery Route, Technology, Drug Type, End User, Sales Channel - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 190 Pages
  • Global
From
Novel Drug Delivery Systems (NDDS) - Global Strategic Business Report - Product Image

Novel Drug Delivery Systems (NDDS) - Global Strategic Business Report

  • Report
  • 492 Pages
  • Global
From
Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From

About the Drug Delivery System Market

The Drug Delivery System market is a subset of the pharmaceutical industry that focuses on the development and manufacture of drug delivery systems. These systems are designed to deliver drugs to the body in a safe and effective manner. Drug delivery systems can be divided into two main categories: active and passive. Active drug delivery systems involve the use of a device to actively transport the drug to the target site, while passive drug delivery systems rely on the body's natural processes to deliver the drug. Drug delivery systems are used to improve the efficacy of drugs, reduce side effects, and increase patient compliance. They can also be used to target specific areas of the body, such as the lungs or the brain. The Drug Delivery System market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.